Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms: Report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritic cell tumors

Karen L. Grogg, Marick E. Lae, Paul J. Kurtin, William R. Macon

Research output: Contribution to journalArticle

99 Scopus citations

Abstract

While tumors of dendritic cell lineage may have overlapping histomorphologic features, most but not all cases can be classified using an immunohistochemical panel, including CD21, CD23, CD35, CD1a, and S-100. Based on observations that clusterin is expressed in benign follicular dendritic cells, clusterin expression in 32 dendritic cell tumors was evaluated. Diffuse strong staining for clusterin was seen in 12 of 12 follicular dendritic cell tumors. Two of these cases were negative for traditional markers (CD21, CD23, CD35); they were classified based on characteristic ultrastructural features. Three of 6 interdigitating dendritic cell tumors were negative for clusterin and 3 showed focal weak positivity. Clusterin staining in Langerhans cell histiocytosis ranged from negative (6 of 14) to weak/moderate (8 of 14). Follicular dendritic cell tumors behaved as benign tumors or low-grade sarcomas. Interdigitating dendritic cell tumors demonstrated a widely variable behavior, ranging from benign to rapidly fatal disease. Based on this initial study, strong clusterin staining supports a diagnosis of follicular dendritic cell tumor. Thus, staining for clusterin is useful in classification of dendritic cell tumors, particularly when the more common markers of follicular dendritic cells are not expressed.

Original languageEnglish (US)
Pages (from-to)988-998
Number of pages11
JournalAmerican Journal of Surgical Pathology
Volume28
Issue number8
DOIs
StatePublished - Aug 1 2004

    Fingerprint

Keywords

  • Clusterin
  • Follicular dendritic cell tumor
  • Immunohistochemistry
  • Interdigitating dendritic cell tumor
  • Langerhans cell histiocytosis

ASJC Scopus subject areas

  • Anatomy
  • Surgery
  • Pathology and Forensic Medicine

Cite this